Mercado europeo de fraccionamiento de plasma: tendencias de la industria y pronóstico hasta 2028

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Healthcare Europe Plasma Fractionation Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo de fraccionamiento de plasma: tendencias de la industria y pronóstico hasta 2028

  • Healthcare
  • Published Report
  • Jul 2021
  • Europe
  • 350 Páginas
  • Número de tablas: 117
  • Número de figuras: 43
Comprar ahoraComprar ahora

>Mercado europeo de fraccionamiento de plasma, por tipo de producto (inmunoglobulinas, concentrados de factores de coagulación, albúmina, inhibidores de proteasa y otros productos), aplicación (neurología, inmunología, hematología, cuidados intensivos, neumología, hemato-oncología, reumatología y otros), tecnología de procesamiento (cromatografía de intercambio iónico, cromatografía de afinidad, criopreservación, ultrafiltración y microfiltración), modo (fraccionamiento de plasma moderno y fraccionamiento de plasma tradicional), usuario final (hospitales y clínicas, laboratorios de investigación clínica, instituciones académicas y otros), canal de distribución (licitaciones directas, distribución de terceros y otros), país (Alemania, Reino Unido, Italia, Francia, España, Suiza, Países Bajos, Rusia, Turquía y resto de Europa) Tendencias de la industria y pronóstico hasta 2028.

Mercado europeo de fraccionamiento de plasmaAnálisis y perspectivas del mercado: mercado de fraccionamiento de plasma en Europa

Se espera que el mercado de fraccionamiento de plasma de Europa gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 5,9% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 2.423,33 millones para 2028. La gran presencia de un número elevado de centros de recolección de plasma está ayudando a la creciente demanda del mercado de fraccionamiento de plasma.

El plasma es un componente sanguíneo que se obtiene a partir de la sangre entera mediante plasmaféresis y se utiliza para diversas aplicaciones terapéuticas y médicas. El plasma humano es una fuente de numerosas proteínas diferentes. Sin embargo, solo algunas de estas proteínas son útiles para producir productos plasmáticos terapéuticos . El proceso de separación, extracción y purificación de estas proteínas del plasma se denomina proceso de fraccionamiento .

El mercado europeo de fraccionamiento de plasma está creciendo debido a factores como el aumento de las enfermedades respiratorias en todo el mundo, el aumento de la población que envejece con enfermedades relacionadas con la sangre y el aumento del uso de inmunoglobulinas. El aumento de las enfermedades raras que requieren el uso de terapia con plasma o derivados del plasma también actúa como un factor importante para el crecimiento del mercado. El aumento de la inversión en investigación y desarrollo también ha dado un auge al mercado europeo de fraccionamiento de plasma.

Sin embargo, las estrictas regulaciones gubernamentales en relación con las terapias con plasma están restringiendo el crecimiento del mercado de fraccionamiento de plasma. Además, la escasez de proteínas plasmáticas actúa como un obstáculo para el crecimiento del mercado.

This plasma fractionation market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Mercado europeo de fraccionamiento de plasmaEurope Plasma Fractionation Market Scope and Market Size

Europe plasma fractionation market is segmented into six notable segments which are based on the product type, application, processing technology, mode, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products. In 2021, immunoglobulin has the largest market share owing to the factors that they can be used in the treatment of immunodeficiency and auto immune disorders treatments.
  • On the basis of application, the plasma fractionation market is segmented into neurology, immunology, haematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, immunology has the largest market share owing to the factors increasing in the incidences of immunology disorders among the patients.
  • On the basis of processing technology, the plasma fractionation market is segmented into Ion- exchange chromatography, affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the factor such as the increasing efficiency by using ionic substances and charged molecules.
  • On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions have the largest market share owing to the factors such as the adopting new equipment and techniques for the plasma fractionation process.
  • On the basis of end user, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics has the largest market share due to increase in the emergency cases where the patients need to be treated effective and permanently.
  • On the basis of distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others. In 2021, direct tenders have the largest market share due to the ease if distribution of the plasma products with a lot of consumer interest.

Europe Plasma Fractionation Market: Country Level Analysis

Europe plasma fractionation market is analysed and market size information is provided by country, product type, application, processing technology, mode, end user and distribution channel as referenced above.

The countries covered in the Europe plasma fractionation market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland and rest of Europe.

Germany is dominating in the Europe plasma fractionation market with the highest CAGR due to increase in the demand for plasma fractionation and growing concern over the human health.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Plasma Fractionation

Europe plasma fractionation market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in plasma fractionation and changes in regulatory scenarios with their support for the plasma fractionation product market. The data is available for historic period 2010-2019.

Competitive Landscape and Europe Plasma Fractionation Market Share Analysis

Europe plasma fractionation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe plasma fractionation market.

Some of the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, LFB SA, Green Cross Corp., Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, Bharat Serums and Vaccines Limited (BSV), Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Numerosas empresas de todo el mundo también están lanzando productos que aceleran el crecimiento del mercado de fraccionamiento de plasma en Europa.

Por ejemplo,

  • En abril de 2020, Grifols lanzó un vial de 3 ml de Hyper RAB, que es inmunoglobulina antirrábica, en el mercado de fraccionamiento de plasma para ayudar en el tratamiento de casos de rabia en todo el mundo.

La colaboración, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando la presencia de la empresa en el mercado de fraccionamiento de plasma, lo que también proporciona beneficios a la organización en su ritmo de crecimiento.

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe plasma fractionation market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET APPLICATION COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. PRODUCTION FACILITIES FOR BLOOD PLASMA:
    2. Suppliers of process lines for plasma fractionation
      1. RAW MATERIAL PROCUREMENT
      2. MANUFACTURING
      3. MARKETING & DISTRIBUTION
      4. END-USERS
  5. EUROPE PLASMA FRACTIONATION MARKET: REGULATORY
    1. THE U.S.
    2. INDIA
    3. EUROPE
    4. BRAZIL
    5. SOUTH AFRICA
  6. MARKET OVERVIEW
    1. 3.1 DRIVERS
      1. 3.1.1 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE
      2. RISE IN RESPIRATORY DISEASES ACROSS THE WORLD
      3. INCREASE IN AGING POPULATION WITH BLOOD-RELATED AILMENTS
      4. INCREASE USAGE OF IMMUNOGLOBULIN
    2. RESTRAINTS
      1. GROWING USAGE OF RECOMBINANT PROTEIN PRODUCTS
      2. STRINGENT GOVERNMENT REGULATIONS REGARDING PLASMA THERAPY
      3. RISK OF QUALITY AND SAFETY
    3. OPPORTUNITIES
      1. INCREASE IN PLASMA COLLECTION CENTRES
      2. UNHEALTHY LIFESTYLE POSSESS SERIOUS INFLAMMATION RISK
      3. ADVANCEMENT IN TECHNOLOGIES
    4. CHALLENGES
      1. SHORTAGE OF PLASMA PROTEINS
      2. HIGH COST OF PLASMA THERAPY
  7. IMPACT OF COVID-19 ON THE EUROPE PLASMA FRACTIONATION MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  8. Europe Plasma fractionation market, by Product type
    1. overview
    2. immunoglobulins
      1. Intravenous Immunoglobulins
      2. Subcutaneous Immunoglobulins
      3. Other Immunoglobulins
    3. coagulation factor concentrates
      1. factor IX
      2. Factor VIII
      3. Fibrinogen Concentrates
      4. Prothrombin Complex Concentrate
      5. Von Willebrand Factor
      6. factor XIII
    4. Albumin
    5. Protease Inhibitors
    6. other Products
  9. Europe Plasma fractionation market, by Application
    1. overview
    2. Immunology
    3. Haematology
    4. critical Care
    5. Neurology
    6. Pulmonology
    7. Haemato-Oncology
    8. Rheumatology
    9. other Application
  10. Europe Plasma fractionation market, by Processing Technology
    1. overview
    2. Ion-Exchange Chromatography
    3. Affinity Chromatography
    4. Ultrafiltration
    5. Microfiltration
    6. Cryoprecipitation
  11. Europe Plasma fractionation market, by mode
    1. overview
    2. Modern Plasma fractionation
    3. Traditional Plasma fractionation
  12. Europe Plasma fractionation market, by end user
    1. overview
    2. Hospitals & Clinics
    3. Clinical Research Laboratories
    4. Academic Institutes
    5. others
  13. Europe Plasma fractionation market, by distribution channel
    1. overview
    2. Direct Tenders
    3. Third Party Distribution
    4. others
  14. EUROPE Plasma Fractionation market, by REGION
    1. Europe
      1. GERMANY
      2. France
      3. U.K.
      4. italy
      5. spain
      6. russia
      7. turkey
      8. netherlands
      9. switzerland
      10. rest of europe
  15. Europe PLASMA FRACTIONATION Market: COMPANY landscape
    1. company share analysis: Europe
  16. swot analysis
  17. company profile
    1. CSL PLASMA
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. GRIFOLS, S.A.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. OCTAPHARMA ag
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. KENDRION S.P.A
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Takeda Pharmaceutical Company Limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. baxter
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. ADMA BIOLOGICS INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. bharat serums and vaccines limited (BSV)
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Bio Products Laboratory Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. biotest AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Boccard
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. CENTURION İlaç Sanayi ve Ticaret A.Ş.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. China Biologic Products Holdings, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. green cross CORP.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. intas pharmaceutical ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. japan blood products Organization
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    17. KABAFUSION
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. LFB SA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. Merck kgaa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. NOVASEP HOLDING SAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    21. PALL CORPORATION
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    22. sanquin
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    23. shanghai raas
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    24. SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    25. Sk plasma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  18. questionnaire
  19. related reports

Lista de Tablas

TABLE 1 Europe Plasma fractionation Market, by Product type, 2019-2028 (USD million)

TABLE 2 Europe Immunoglobulins in Plasma fractionation Market, By Region, 2019-2028 (USD Million)

TABLE 3 Europe Immunoglobulins in Plasma fractionation Market, Product type, 2019-2028 (USD million)

TABLE 4 Europe Coagulation factor concentrates in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 5 Europe Coagulation factor concentrates in Plasma fractionation Market, Product type, 2019-2028 (USD million)

TABLE 6 Europe Albumin in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 7 Europe Protease Inhibitors in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 8 Europe Other Products in Plasma fractionation Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Plasma fractionation Market, application, 2019-2028 (USD million)

TABLE 10 Europe Immunology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 11 Europe Haematology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 12 Europe Critical care in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 13 Europe Neurology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 14 Europe Pulmonology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 15 Europe Haemato-Oncology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 16 Europe Rheumatology in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 17 Europe Other Application in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 18 Europe Plasma fractionation Market, Processing Technology, 2019-2028 (USD million)

TABLE 19 Europe Ion-Exchange Chromatography in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 20 Europe Affinity Chromatography in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 21 Europe Ultrafiltration in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 22 Europe Microfiltration in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 23 Europe Cryoprecipitation in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 24 Europe Plasma fractionation Market, mode, 2019-2028 (USD million)

TABLE 25 Europe Modern Plasma fractionation in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 26 Europe Traditional Plasma fractionation in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 27 Europe Plasma fractionation Market, end user, 2019-2028 (USD million)

TABLE 28 Europe Hospitals & Clinics in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 29 Europe Clinical Research Laboratories in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 30 Europe Academic Institutes in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 31 Europe Others in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 32 Europe Plasma fractionation Market, distribution channel, 2019-2028 (USD million)

TABLE 33 Europe Direct Tenders in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 34 Europe Third Party Distribution in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 35 Europe Others in Plasma fractionation Market, by region, 2019-2028 (USD million)

TABLE 36 Europe plasma fractionation market, By COUNTRY, 2019-2028 (USD million)

TABLE 37 Europe Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 38 Europe immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 39 Europe Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 40 Europe Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 41 Europe Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 42 Europe Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 43 Europe Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 44 Europe Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 45 Germany Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 46 Germany immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 47 Germany Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 48 Germany Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 49 Germany Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 50 Germany Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 51 Germany Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 52 Germany Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 53 france Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 54 france immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 55 france Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 56 france Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 57 france Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 58 france Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 59 france Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 60 france Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 61 U.K. Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 62 U.K. immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 63 U.K. Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 64 U.K. Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 65 U.K. Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 66 U.K. Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 67 U.K. Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 68 U.K. Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 69 italy Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 70 italy immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 71 italy Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 72 italy Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 73 italy Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 74 italy Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 75 italy Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 76 italy Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 77 Spain Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 78 Spain immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 79 Spain Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 80 Spain Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 81 Spain Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 82 Spain Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 83 Spain Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 84 Spain Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 85 Russia Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 86 Russia immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 87 Russia Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 88 Russia Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 89 Russia Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 90 Russia Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 91 Russia Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 92 Russia Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 93 Turkey Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 94 Turkey immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 95 Turkey Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 96 Turkey Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 97 Turkey Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 98 Turkey Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 99 Turkey Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 100 Turkey Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 101 Netherlands Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 102 Netherlands immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 103 Netherlands Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 104 Netherlands Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 105 Netherlands Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 106 Netherlands Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 107 Netherlands Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 108 Netherlands Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 109 Switzerland Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

TABLE 110 Switzerland immunoglobulins in plasma fractionation market, By product type, 2019-2028 (USD million)

TABLE 111 Switzerland Coagulation factor concentrates in Plasma fractionation Market, By product type, 2019-2028 (USD Million)

TABLE 112 Switzerland Plasma fractionation Market, By application, 2019-2028 (USD Million)

TABLE 113 Switzerland Plasma fractionation Market, By processing technology, 2019-2028 (USD Million)

TABLE 114 Switzerland Plasma fractionation Market, By mode, 2019-2028 (USD Million)

TABLE 115 Switzerland Plasma fractionation Market, By end user, 2019-2028 (USD Million)

TABLE 116 Switzerland Plasma fractionation Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 117 Rest of Europe Plasma fractionation Market, By Product type, 2019-2028 (USD Million)

Lista de figuras

FIGURE 1 Europe plasma fractionation MARKET: segmentation

FIGURE 2 EUROPE PLASMA FRACTIONATION MARKET : data triangulation

FIGURE 3 Europe plasma fractionation MARKET: DROC ANALYSIS

FIGURE 4 Europe plasma fractionation MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE PLASMA FRACTIONATION MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE PLASMA FRACTIONATION MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe plasma fractionation MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE PLASMA FRACTIONATION MARKET : vendor share analysis

FIGURE 9 Europe plasma fractionation market: MARKET APPLICATION COVERAGE GRID

FIGURE 10 Europe plasma fractionation MARKET: SEGMENTATION

FIGURE 11 Increase in rare diseases that requires use of plasma therapy or plasma derivative is expected to drive the growth of the Europe plasma fractionation market IN THE FORECAST PERIOD of 2021 To 2028

FIGURE 12 immunoglobulins segment is expected to account for the largest share of the Europe plasma fractionation market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE PLASMA FRACTIONATION MARKET

FIGURE 14 Europe Plasma fractionation Market: BY Product Type, 2020

FIGURE 15 Europe Plasma fractionation Market: BY Product Type, 2020-2028 (USD Million)

FIGURE 16 Europe Plasma fractionation Market: BY Product Type, CAGR (2020-2028)

FIGURE 17 Europe Plasma fractionation Market: BY Product Type, LIFELINE CURVE

FIGURE 18 Europe Plasma fractionation Market: BY application, 2020

FIGURE 19 Europe Plasma fractionation Market: BY application, 2020-2028 (USD Million)

FIGURE 20 Europe Plasma fractionation Market: BY application, CAGR (2020-2028)

FIGURE 21 Europe Plasma fractionation Market: BY application, LIFELINE CURVE

FIGURE 22 Europe Plasma fractionation Market: BY Processing Technology, 2020

FIGURE 23 Europe Plasma fractionation Market: BY Processing Technology, 2020-2028 (USD Million)

FIGURE 24 Europe Plasma fractionation Market: BY Processing Technology, CAGR (2020-2028)

FIGURE 25 Europe Plasma fractionation Market: BY Processing Technology, LIFELINE CURVE

FIGURE 26 Europe Plasma fractionation Market: BY mode, 2020

FIGURE 27 Europe Plasma fractionation Market: BY mode, 2020-2028 (USD Million)

FIGURE 28 Europe Plasma fractionation Market: BY mode, CAGR (2020-2028)

FIGURE 29 Europe Plasma fractionation Market: BY mode, LIFELINE CURVE

FIGURE 30 Europe Plasma fractionation Market: BY end user, 2020

FIGURE 31 Europe Plasma fractionation Market: BY end user, 2020-2028 (USD Million)

FIGURE 32 Europe Plasma fractionation Market: BY end user, CAGR (2020-2028)

FIGURE 33 Europe Plasma fractionation Market: BY end user, LIFELINE CURVE

FIGURE 34 Europe Plasma fractionation Market: BY distribution channel, 2020

FIGURE 35 Europe Plasma fractionation Market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 36 Europe Plasma fractionation Market: BY distribution channel, CAGR (2020-2028)

FIGURE 37 Europe Plasma fractionation Market: BY distribution channel, LIFELINE CURVE

FIGURE 38 Europe plasma fractionation market: SNAPSHOT (2020)

FIGURE 39 Europe plasma fractionation market: BY COUNTRY (2020)

FIGURE 40 Europe plasma fractionation market: BY COUNTRY (2021 & 2028)

FIGURE 41 Europe plasma fractionation market: BY COUNTRY (2020 & 2028)

FIGURE 42 Europe plasma fractionation market: BY PRODUCT TYPE (2021 & 2028)

FIGURE 43 Europe Plasma Fractionation Market: company share 2020 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Explorar páginas relacionadas

Banner